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Abstract
Background: Cases with essential tremor (ET) have been described with Lewy body inclusions, the hallmark of Parkinson disease (PD). Patients with PD may
suffer from anosmia, depression, constipation, and rapid eye movement sleep behavior disorder (RBD), sometimes years before the appearance of their motor
syndrome. The objective of this study was to evaluate the prevalence of these non-motor Parkinson’s associated symptoms in patients with ET.
Methods: Fifty ET subjects were contacted by phone and given questionnaires evaluating the presence or absence of anosmia, depression, constipation, and RBD.
Frequencies of these symptoms were compared with their published prevalence in the general population.
Results: Of the patients with ET, 4.5% reported having anosmia or hyposmia and 21.7% reported being constipated, similar to what is observed in the general
population. Using a screening questionnaire for RBD, 43.5% of ET patients are possibly suffering from RBD, whereas in the general population prevalence is
estimated to be 0.5%. Finally, depression was detected in 21.7% of ET patients; in the general population, prevalence is 5%.
Discussion: Patients with ET seem to have more RBD and more depression than found in the general population. Prospective studies with normal control groups
are needed to confirm these findings.
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Introduction
Essential tremor (ET) is the most prevalent movement disorder, with
a prevalence of 4–5.6% (age >40 years) that increases with age,1,2 yet
some aspects of its clinical manifestations need clarification. ET is
classically defined as a disease with exclusively motor features. The
cornerstone characteristic of ET is an 8–12 Hz kinetic tremor of both
upper limbs (90–95%), which can be asymmetrical, and may be
accompanied by head (30%), legs (10–15%), and voice (20%) tremors.3
The population of ET patients is phenotypically heterogeneous; not
every patient develops head tremor, and some patients even develop
rest tremor,4–6 a feature highly characteristic of PD patients. In fact,
ET is so heterogeneous that it is probably the most commonly
misdiagnosed neurological disorder.7 Some studies have found that up
to 30–50% of patients with an ET diagnosis actually do not have ET.8
Recently, several studies have uncovered non-motor features of
ET,9 including decreased olfaction, depression, and rapid eye move-
ment sleep behavior disorder (RBD). Amongst the studies that
evaluated olfaction in ET patients, some have found a decrease,10,11
although others did not.12–14 The co-occurrence of ET and depression
has been observed with a high frequency.15–18 Only one study has
evaluated the prevalence of RBD in ET patients19 and found no
evidence of an increased incidence of RBD. Finally, no study has
evaluated the occurrence of constipation in ET patients.
Recent analysis of ET brains has unveiled two types of changes that
possibly indicate two different mechanisms for the pathogenesis of
ET.20 Approximately 75% of the studied brains have cerebellar
changes (torpedo cells), whereas other brains had Lewy bodies in the
locus ceruleus, defining a ‘‘Lewy bodies ET’’ subtype. A link between
PD and ET has been debated for years and the relationship between
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the two disorders is still unclear. Pre-existing ET is a risk factor for the
development of PD, the risk being slightly to highly increased
depending on the study,21–23 with a fourfold increased risk being a
figure commonly accepted.24 The two diseases may have a common
genetic background: genome-wide association studies have found
specific single nucleotide polymorphism in the leucine-rich repeat and Ig
containing 1 gene (LINGO1) as a risk for both PD and ET,25 providing a
genetic link between the two disorders, whereas others studies did
not.26
Obviously, even though ET is the most prevalent movement
disorder, we have limited knowledge regarding its pathogenesis, its
relationship to PD, and its non-motor features are just starting to be
unveiled. We thus hypothesized that ET patients may have a higher
prevalence of pre-clinical features that are associated with PD, namely
depression, anosmia, constipation, and RBD.
Methods
Study population
Consecutive patients from a list of patients who had previously
participated in a field survey about ET were contacted by phone and
verbal informed consent was obtained. Diagnosis of ET had been
previously made by a movement disorder specialist, based on specific
criteria according to the Tremor Investigation Group (TRIG),27 which
classify the degree of diagnosis certainty as confirmed, probable, or
possible. Only participants who received a diagnosis of ET were
contacted. Calls were carried out from June 30, 2011, to July 15, 2011.
This study was approved by the research and ethics board of the
University of Montreal Health Centre.
Evaluation of subjects
The following information was updated and recorded for each
contacted subject, either from patient records or direct questioning:
brief medical history, current drugs, alcohol intake, and smoking
status. In order to evaluate olfactory function, RBD, constipation, and
depression, the following questionnaires were performed by telephone
interview.
Olfaction. Since no questionnaire is available to evaluate olfaction, we
evaluated olfaction by simply asking patients if they have noted a
change in their ability to smell or taste.
Rapid eye movement sleep behavior disorder. We used the REM
Sleep Behavior Disorder Screening Questionnaire (RBDSQ).28 The
RBDSQ is a 10-item instrument that assesses the subject’s sleep
behavior with short questions that have to be answered by yes or no.
This questionnaire addresses 1) the frequency and contents of dreams
and their relationship to movements during sleep, 2) self-injuries and
injuries to the bed partner, 3) motor behavior while asleep (talking,
sudden movements), 4) awakening and disturbed sleep and finally, 5)
the presence of any neurological disorder. The cut-off for a positive test
result is >5 with a sensitivity of 96% and a specificity of 92%.
Constipation. The diagnosis of functional constipation was based on
the Rome III diagnostic criteria.29 The diagnosis criteria must include
two or more of the following items for at least 25% of defecations: 1)
straining, 2) lumpy or hard stools, 3) sensation of incomplete
evacuation, 4) sensation of anorectal obstruction/blockade, 5) manual
maneuvers to facilitate defecations, 6) fewer than three defecations per
week. Moreover, loose stools are merely present without laxative use.
The symptoms above should be present for the last 3 months and have
started at least 6 months prior to diagnosis. Participants who received a
diagnosis of constipation and were treated with laxatives were also
considered as having constipation.
Depression. We used the geriatric depression scale-15 (GDS-15)30,31 to
screen for the presence of current depression in ET patients. This is a
15-item yes/no questionnaire that does not focus on somatic symptoms
and has no question on suicide. A score between 5 and 9 was
categorized as a minor depressive disorder and a score of 10 and above
as a major depressive disorder.32 We also asked whether patients were
diagnosed with depression in their past.
Prevalence of anosmia, depression, constipation and RBD were
obtained through a literature review. These data were thus used as a
historical control.
Statistical analysis
Statistical analyses were performed in SPSS (Version 17.0), using




We contacted 63 patients. One patient was not able to complete the
telephone interview because of a hearing deficit. Another patient
refused to participate and did not provide any reason. One patient was
deceased, and, finally, 14 patients did not return our calls. Of these
there were 10 males and four females. The mean age of these 14
patients was 50¡17 years. Forty-six participants completed the
questionnaires. More females (33 [71.7%]) were interviewed than
males (13 [28.3%]). The mean age of the participants was
57.17¡19.48 years, with a range of 13–86 years. Mean duration of
ET of our subjects was 24.67¡19.80 years and mean age of onset of
ET was 31.49¡22.57. There were no significant differences between
female and male subgroups (Table 1) in terms of age at the time of the
interview (p50.395), duration of ET (p50.102), age of onset of ET
(p50.426), ET diagnosis (p50.559), dominance (p50.788), alcohol
intake (p50.496), caffeine consumption (p50.523), and tobacco use
(p50.351).
Non-motor symptoms
Table 2 summarizes the non-motor symptoms. In our sample of 46
patients, two participants reported olfaction change or loss (4.5%). A
substantial number of subjects (20 patients or 43.5% of the sample)
reach the positive cut-off of 5 at the RBDSQ, suggesting that they
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might be affected by RBD. When looking at the sex of the RBD-
positive subjects, 14 (70%) were females while 6 (30%) were males.
Regarding the occurrence of constipation in our sample, nine subjects
met the ROME III criteria while one patient reported using laxatives
(without a concomitant constipation history), for a total of 10 subjects
(21.7%). More women (eight) suffered from constipation than men (two).
Nine participants (19.6%) scored between five and nine on the
GDS-15 test, suggesting a minor depressive disorder, whereas one
patient (2.2%) scored above 10, suggesting major depressive disorder.
The male/female ratio in our sample was 3:7. In addition, 17 patients
(37%) reported previous diagnosis of depression, 14 of them being
female patients.
Discussion
In our sample of 46 patients with ET, we found a higher prevalence
of RBD, and depression but not of anosmia or constipation.
A positive score for RBD was obtained in 43.5% of the subjects. Of
note, two of our patients reported suffering from sleep apnea; the effect
Table 1. Demographic Data
Variables Female (71.7%) (n533) Male (28.3%) (n513) Total (n546)
Age in years, m¡s (range) 58.73¡19.55 (13–86) 53.23¡19.48 (20–75) 57.17¡19.48 (13–86)
Duration of ET, m¡s (range) 27.84¡19.32 (3–66) 17.54¡17.23 (3–59) 24.87¡19.14 (3–66)
Age of onset, m¡s (range) 29.78¡22.97 (1–75) 35.69¡21.84 (10–69) 31.49¡22.57 (1–75)
ET diagnosis, n (%)
N Confirmed 14 (42.42) 5 (38.46) 19 (41.3)
N Probable 6 (18.18) 5 (38.46) 11 (23.9)
N Possible 10 (30.30) 3 (23.07) 13 (28.3)
N Others 3 (9.09) 0 (0) 3 (6.5)
Dominance, n (%)
N Right 26 (78.8) 11 (84.6) 37 (80.4)
N Left 5 (15.2) 1 (7.7) 6 (13)
N Ambidextrous 2 (6.1) 1 (7.7) 3 (6.5)
Alcohol consumers, n (%) 22 (66.7) 10 (76.9) 32 (69.6)
Caffeine consumers, n (%) 28 (84.8) 10 (76.9) 38 (82.6)
Smokers, n (%) 6 (18.2) 4 (30.8) 10 (21.7)
ET, Essential Tremor; m, Mean, s, Standard Deviation.
Table 2. Non-Motor Symptoms in Participants with Essential Tremor
Non-Motor Symptoms Total (n546) General Population (% only)
Olfaction change/loss, n (%) 2 (4.5) 1.6%33
RBD, n (%) 20 (43.5) 0.5%34
Constipation, n (%) 10 (21.7) 19.4%29
Depression, n (%) 10 (21.7) 5%35
Previous depression, n (%) 17 (37) 17%35
RBD, Rapid Eye Movement Sleep Behavior Disorder.
Non-motor Symptoms in Essential Tremor Lacerte A, Chouinard S, Jodoin N, et al.
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services3
of this concomitant condition on the specificity of the RBDSQ is
currently unknown.28
Interestingly, this number is very high compared to the prevalence
in the general population which is estimated at 0.5%.34 So far, only
one other group has evaluated the prevalence of RBD in ET patients,
using a different questionnaire, and found no evidence of an increased
frequency of RBD.19 In this study, probable RBD diagnosis was
assigned to subjects on the basis of a unique question assessing dream
acting only. As the questionnaire used in our study evaluates most
aspects of RBD, its sensitivity and specificity are high, as determined
by Stiasny-Kolster.28
The prevalence of RBD is of course also much higher in patients
with a-synucleinopathies: Parkinson’s disease (between 14.6% and
33%36,37), and multiple system atrophy (69%38). This is comparable
with the prevalence that we obtained in our survey and could support
involvement of the same brainstem structures that are responsible for
this sleep disorder, or perhaps similar synuclein pathology.
In our subjects, 21.7% were depressed and 37% had a depression
history, which is higher than the 5% and 17% lifetime prevalence in
the general population.35 Most patients with a history of depression
developed ET at a young age (before 41). A twofold greater depression
prevalence in females than in males was observed in our sample, which
is also commonly reported in the general population.35 A previous
study had found that 34% of ET patients were at least mildly
depressed, according to the Beck Depression Inventory (BDI).15 In the
same study, 48% of PD patients were found to be depressed. In our
cohort, the prevalence of depression is thus in between that of the
general population and the PD population.
In our study, two patients out of 46 (4.5%) reported anosmia/
hyposmia whereas in the general population, self-reported prevalence
of anosmia/hyposmia is 1.6%.33 Most studies have not found
hyposmia in ET patients,12,13,39 whereas other studies have shown a
small diminution of olfaction,10,11,40,41 albeit to a lesser degree than in
PD patients. The number that we found may be an underestimate
since decreased olfactory function is likely often subclinical.10,11,40,41
We also did not find different rates of constipation in our patients
compared to the general population: 21.7% of our subjects presented
constipation, whereas constipation occurs in up to 27% of people
depending on demographic factors, and the constipation definition
used to perform the study.29
It remains unclear why both depression and RBD are so common in
ET patients. Are these markers more specific to ET than constipation
and olfaction deficit? Are they specific to brainstem structures involved
in ET by Lewy bodies?
This study has a number of important limitations but we feel it
provides some preliminary data that would be interesting to pursue
with prospective studies using a larger number of patients, including a
matched control group for age and sex, among other things. Also,
using a validated questionnaire against more definitive measures such
as polysomnography to confirm RBD and smell tests for anosmia
would increase the reliability.42
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